Bugat Pal Korhaz
About Bugat Pal Korhaz
- Top Sponsors
- Top Collaborators
- Trials By Phase
- Recruitment Status
- Top Conditions
- Intervention Types
- Top Intervention Names
- Trials By Gender
Lead Sponsor
# Trials
Clinical Trials at Bugat Pal Korhaz
During the past decade, Bugat Pal Korhaz conducted 37 clinical trials. In the 10-year time frame, 37 clinical trials started and 14 clinical trials were completed, i.e. on
average, 37.8% percent of trials that started reached the finish line to date. In the past 5 years, 19 clinical trials started and 11 clinical trials were completed. i.e. 57.9%
of trials that started reached the finish line.
Trials List
Trail ID
Brief Title
Start Date
Completion Date
Status
Enrollment
Vernakalant (Oral) Prevention of Atrial Fibrillation Recurrence Post-Conversion Study
2007-03-01
2008-07-01
Completed
735
A Study To Investigate Safety And Efficacy Of CP-690,550 For Induction Therapy In Subjects With Moderate To Severe Crohn's Disease
2011-10-01
2015-03-01
Completed
280
The Safety And Efficacy Of Maintenance Therapy With CP-690,550
2012-03-01
2015-07-01
Completed
180
A Open-Label Study Of CP-690,550 As Long-Term Therapy (48 Weeks) In Subjects With Crohn's Disease
2012-04-01
2016-07-01
Completed
150
Extended Access Program of Vedolizumab IV in Ulcerative Colitis and Crohn's Disease
2016-08-01
2023-01-11
Completed
329
Treatment of Adenoviral Conjunctivitis With SHP640 Compared to Povidone-iodine (PVP-I) and Placebo
2017-03-27
2019-05-13
Terminated
219
EMPagliflozin outcomE tRial in Patients With chrOnic heaRt Failure With Preserved Ejection Fraction (EMPEROR-Preserved)
2017-03-02
2021-04-26
Completed
5,988
EMPagliflozin outcomE tRial in Patients With chrOnic heaRt Failure With Reduced Ejection Fraction (EMPEROR-Reduced)
2017-03-06
2020-05-28
Completed
3,730
Clinical Trials Sponsors and Collaborators
Out of the total clinical trials conducted in "Bugat Pal Korhaz" #1 sponsor was "Janssen Research & Development, LLC" with 6 trials, followed by "Pfizer" with 6 trials
sponsored, "Eli Lilly and Company" with 5 trials sponsored, "Boehringer Ingelheim" with 3 trials sponsored and "Arena Pharmaceuticals"
with 3 trials sponsored. Other sponsors include 14 different institutions and
companies that sponsored additional 22 trials in total.
In terms of collaborators to trials, out of the total clinical trials conducted in "Bugat Pal Korhaz"
#1 collaborator was "Arena is a wholly owned subsidiary of Pfizer" with 3 trials as a collaborator, "Eli Lilly and Company" with 2 trials as a collaborator, "Centessa Pharmaceuticals plc" with 1 trials as a collaborator, "Dr. Falk Pharma GmbH" with 1 trials as a collaborator and "Medpace, Inc." with 1 trials as a collaborator. Other collaborators include -4 different institutions and companies that were
collaborators in the rest 6 trials.
Clinical Trials Conditions at Bugat Pal Korhaz
According to Clinical.Site data, the most researched conditions in "Bugat Pal Korhaz" are
"Crohn's Disease" (7 trials), "Depressive Disorder, Major" (7 trials), "Ulcerative Colitis" (7 trials), "Colitis, Ulcerative" (4 trials) and "Heart Failure" (3 trials). Many other conditions were trialed in "Bugat Pal Korhaz" in a lesser frequency.
Clinical Trials Intervention Types at Bugat Pal Korhaz
Most popular intervention types in "Bugat Pal Korhaz" are "Drug" (39 trials), "Other" (6 trials), "Biological" (2 trials) and "Device" (1 trials). Other intervention types were less common.
The name of intervention was led by "Placebo" (28 trials), "Etrasimod" (5 trials), "CP-690,550" (3 trials), "Guselkumab" (3 trials) and "Aticaprant" (2 trials). Other intervention names were less common.
Clinical Trials Genders at Bugat Pal Korhaz
The vast majority of trials in "Bugat Pal Korhaz" are
41 trials for "All" genders.
Clinical Trials Status at Bugat Pal Korhaz
Currently, there are NaN active trials in "Bugat Pal Korhaz".
undefined are not yet recruiting,
10 are recruiting,
8 are Active, not recruiting,
and undefined are Enrolling by invitation.
In total, there were 14 completed trials in Bugat Pal Korhaz,
undefined suspended trials,
and 9 terminated clinical trials to date.
Out of the total trials that were conducted in Bugat Pal Korhaz, 0 "Phase 1"
clinical trials were conducted, 16 "Phase 2" clinical
trials and 22 "Phase 3" clinical trials were conducted as
well. "Phase 4" trials included 2 trials, and there were
also 2 trials that are defined as “Not Applicable".